Skip to main content

. 1986 Aug 9;293(6543):367–368. doi: 10.1136/bmj.293.6543.367

Awareness and use of glucagon in diabetics treated with insulin.

D M Matthews, A W Patrick, D A Collier, H A Kellett, J M Steel, B F Clarke, C C MacIntyre

PMCID: PMC1341055 PMID: 3089525

368

Images in this article

p368-a
on p.368

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Casparie A. F., Elving L. D. Severe hypoglycemia in diabetic patients: frequency, causes, prevention. Diabetes Care. 1985 Mar-Apr;8(2):141–145. doi: 10.2337/diacare.8.2.141. [DOI] [PubMed] [Google Scholar]
Mühlhauser I., Koch J., Berger M. Pharmacokinetics and bioavailability of injected glucagon: differences between intramuscular, subcutaneous, and intravenous administration. Diabetes Care. 1985 Jan-Feb;8(1):39–42. doi: 10.2337/diacare.8.1.39. [DOI] [PubMed] [Google Scholar]
Potter J., Clarke P., Gale E. A., Dave S. H., Tattersall R. B. Insulin-induced hypoglycaemia in an accident and emergency department: the tip of an iceberg? Br Med J (Clin Res Ed) 1982 Oct 23;285(6349):1180–1182. doi: 10.1136/bmj.285.6349.1180. [DOI] [PMC free article] [PubMed] [Google Scholar]
Tunbridge W. M. Factors contributing to deaths of diabetics under fifty years of age. On behalf of the Medical Services Study Group and British Diabetic Association. Lancet. 1981 Sep 12;2(8246):569–572. doi: 10.1016/s0140-6736(81)90950-8. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES